GlassScriptPhysician profile
Stacy L Leonard
NPI 1891890786
$251.20
in general payments reported to CMS, 2019-2025
10 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.05 · 2021: $16.22 · 2023: $16.46 · 2024: $50.58 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $75.20 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $43.18 | 2025 | Novasure, Myosure Tissue Removal Device |
| Exact Sciences Corporation | $21.97 | 2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.17 | 2025 | Jardiance |
| Exeltis, USA INC. | $16.46 | 2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $16.22 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $16.20 | 2024 | |
| Novo Nordisk INC | $15.09 | 2025 | Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $14.66 | 2025 | Trintellix |
| Abiomed | $13.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Leonard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.